OtherPractice

Problem-based deprescribing

Using your patients’ clinical concerns to guide medication review

Frank Molnar and Chris Frank
Canadian Family Physician April 2019; 65 (4) 266;

Clinical question

How can I best approach deprescribing for my medically complex frail seniors?

Bottom line

A recently published article in the Canadian Geriatrics Society Journal of CME provides a practical approach to deprescribing with older patients who have complex health issues.1 Many FPs take a problem-based approach to optimizing medications rather than doing medication reviews as a stand-alone activity.

Evidence

  • Polypharmacy, defined as using more medications or a higher dose than clinically indicated, is more common in the geriatric population and increases the risk of adverse drug events (ADEs).2

  • Older patients are at greater risk of ADEs owing to body composition and physiology changes that result in altered pharmacokinetic and pharmacodynamic properties of medications, as well as owing to interactions with other medications.3

  • These risks are sometimes not fully appreciated by clinicians, which is supported by the fact that ADEs contribute to up to 20% of hospitalizations in the elderly.4–6

Approach

Seniors typically present to FPs for specific clinical or functional problems (eg, falls, incontinence, cognitive changes, weight loss) rather than to seek a general review of medications. With older patients, FPs should always consider medications as a primary or contributing factor in any clinical presentation and review the patient’s medication list as a key part of care. Any new symptom a patient experiences should be screened as a possible ADE and as a potential opportunity to deprescribe.

While resources such as the Beers criteria7 and the STOPP/START8 (Screening Tool of Older People’s Prescriptions and Screening Tool to Alert to Right Treatment) criteria promote a deprescribing approach, their focus is on the medications themselves and their appropriateness in the geriatric population in general terms. Problem-based deprescribing is a complementary strategy to enhance the use of these “optimal prescribing” criteria and help prioritize a deprescribing focus. Box 19 outlines the steps to promoting problem-based deprescribing.

Box 1.

Steps to problem-based deprescribing

  1. Routinely include ADEs in the differential diagnosis when a patient presents with a new symptom; this helps to recognize ADEs, as well as to avoid prescribing cascades

  2. Prioritize clinical issues according to risk; start problem-based deprescribing by focusing on the highest-risk clinical issues (eg, delirium and falls)

  3. When assessing concerning medications for deprescribing, weigh risk versus benefit of deprescribing and use evidence-based guidelines where available9

  4. Forge a working partnership between the patient, caregiver, other physicians, and pharmacist to determine a plan for deprescribing and for monitoring outcomes

ADE—adverse drug event.

Implementation

The most important step is to consider the role of medications in all concerns brought by your older patients (and younger ones, too!). For additional resources on problem-based deprescribing for common issues like incontinence, anorexia and weight loss, postural hypotension, and falls and delirium, visit canadiangeriatrics.ca/wp-content/uploads/2018/10/5_Frank-Molnar-Article-Formatted-Final.pdf.1 Clinical practice guidelines for deprescribing benzodiazepines, proton pump inhibitors, and antipsychotics can be found at deprescribing.org/resources/deprescribing-guidelines-algorithms.10–12

Notes

Geriatric Gems are produced in association with the Canadian Geriatrics Society Journal of CME, a free peer-reviewed journal published by the Canadian Geriatrics Society (www.geriatricsjournal.ca). The articles summarize evidence from review articles published in the Canadian Geriatrics Society Journal of CME and offer practical approaches for family physicians caring for elderly patients.

Footnotes

  • Competing interests

    None declared

References

  1. 1.↵
    1. Molnar FJ,
    2. Haddad T,
    3. Dyks D,
    4. Farrell B
    . Problem-based deprescribing: a practical patient-centred approach to promoting the use of existing deprescribing resources in frontline care. Can Geriatr Soc J CME 2018;8(2):1-14.
    OpenUrl
  2. 2.↵
    1. Huang AR,
    2. Mallet L,
    3. Rochefort CM,
    4. Eguale T,
    5. Buckeridge DL,
    6. Tamblyn R
    . Medication-related falls in the elderly: causative factors and preventive strategies. Drugs Aging 2012;29(5):359-76.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Lemay G,
    2. Dalziel B
    . Better prescribing in the elderly. Can Geriatr Soc J CME 2012;5(1):20-6.
    OpenUrl
  4. 4.↵
    1. Hart M,
    2. Giancroce P
    . Safer prescribing in elderly patients. Can Geriatr Soc J CME 2015;5(1):16-22.
    OpenUrl
  5. 5.
    1. Hanlon JT,
    2. Schmader KE,
    3. Koronkowski MJ,
    4. Weinberger M,
    5. Landsman PB,
    6. Samsa GP,
    7. et al
    . Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1997;45(8):945-8.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Hamilton H,
    2. Gallagher PF,
    3. O’Mahony D
    . Inappropriate prescribing and adverse drug events in older people. BMC Geriatr 2009;9:5.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. American Geriatrics Society 2015 Beers Criteria Update Expert Panel
    . American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2015;63(11):2227-46.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Hamilton H,
    2. Gallagher P,
    3. Ryan C,
    4. Byrne S,
    5. O’Mahony D
    . Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 2011;171(11):1013-9.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Steinman MA,
    2. Hanlon JT
    . Managing medications in clinically complex elders: “There’s got to be a happy medium”. JAMA 2010;304(14):1592-601.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Pottie K,
    2. Thompson W,
    3. Davies S,
    4. Grenier J,
    5. Sadowski SA,
    6. Welch V,
    7. et al
    . Deprescribing benzodiazepine receptor agonists. Evidence-based clinical practice guideline. Can Fam Physician 2018;64:339-51. (Eng), e209–24 (Fr).
    OpenUrlAbstract/FREE Full Text
  11. 11.
    1. Bjerre LM,
    2. Farrell B,
    3. Hogel M,
    4. Graham L,
    5. Lemay G,
    6. McCarthy L,
    7. et al
    . Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia. Evidence-based clinical practice guideline. Can Fam Physician 2018;64:17-27. (Eng), e1–12 (Fr).
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Farrell B,
    2. Pottie K,
    3. Thompson W,
    4. Boghossian T,
    5. Pizzola L,
    6. Rashid FJ,
    7. et al
    . Deprescribing proton pump inhibitors. Evidence-based clinical practice guideline. Can Fam Physician 2017;63:354-64. (Eng), e253–65 (Fr).
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Respond to this article
Problem-based deprescribing
Frank Molnar, Chris Frank
Canadian Family Physician Apr 2019, 65 (4) 266;
Twitter logo Facebook logo Mendeley logo

Jump to section